Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

Publication | Closed Access

DOI

Citations

References

2018

Year

Antonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, Stylianos Panopoulos, Chrysanthi Staveri, Anastasia Klagou, Christina Tsalapaki, Lamprini Pantazi, Styliani Konsta, Clio P. Mavragani,

Seminars in Arthritis and Rheumatism

Autoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupusSystemic TreatmentImmunosuppressive TherapyImmunologyCorticosteroid DoseAutoimmunityMedicineReal-life Observational Study